Multimodal Neuroimaging Summary Scores as Neurobiological Markers of Psychosis
Schizophrenia Bulletin · 2024
DOI: 10.1093/schbul/sbad149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2024. Verfasst von Amanda L Rodrigue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Schizophrenia, Psychotic Disorders, Diffusion Tensor Imaging, Magnetic Resonance Imaging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, Center for Neuropsychiatric Research Next Generation Award, NICHD NIH HHS.
Abstract (Originalsprache)
Background and Hypothesis Structural brain alterations are well-established features of schizophrenia but they do not effectively predict disease/disease risk. Similar to polygenic risk scores in genetics, we integrated multifactorial aspects of brain structure into a summary “Neuroscore” and examined its potential as a marker of disease. Study Design We extracted measures from T1-weighted scans and diffusion tensor imaging (DTI) models from three studies with schizophrenia and healthy individuals. We calculated individual-level summary scores (Neuroscores) for T1-weighted and DTI measures and a combined score (Multimodal Neuroscore-MM). We assessed each score’s ability to differentiate schizophrenia cases from controls and its relationship to clinical symptomatology, intelligence quotient (IQ), and medication dosage. We assessed Neuroscore specificity by performing all analyses in a more inclusive psychosis sample and by using scores generated from MDD effect sizes. Study Results All Neuroscores significantly differentiated schizophrenia cases from controls (T1 d = 0.56, DTI d = 0.29, MM d = 0.64) to a greater degree than individual brain regions. Higher Neuroscores (ie, increased liability) were associated with lower IQ (T1 β = −0.26, DTI β = −0.15, MM β = −0.30). Higher T1-weighted Neuroscores were associated with higher positive and negative symptom severity (Positive β = 0.21, Negative β = 0.16); Higher Multimodal Neuroscores were associated with higher positive symptom severity (β = 0.30). SZ Neuroscores outperformed MDD Neuroscores in predicting IQ (T1: z = 3.5, q = 0.0007; MM: z = 1.8, q = 0.05). Conclusions Neuroscores are a step toward leveraging widespread structural brain alterations in psychosis to identify robust neurobiological markers of disease. Future studies will assess ways to improve neuroscore calculation, including developing the optimal methods to calculate neuroscores and considering disorder overlap.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Boston Children's Hospital, Boston, MA, USA.
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.
ORCID-Profile: Maria Jalbrzikowski
Förderung
- NIMH NIH HHS
- Center for Neuropsychiatric Research Next Generation Award
- NICHD NIH HHS
- NCRR NIH HHS
- Center of Biomedical Research Excellence
- National Institute of Mental Health
Zitieren
APA
Rodrigue, A. L., Hayes, R. A., Waite, E., Corcoran, M., Glahn, D. C., & Jalbrzikowski, M. (2024). Multimodal Neuroimaging Summary Scores as Neurobiological Markers of Psychosis. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbad149
Vancouver
Rodrigue AL, Hayes RA, Waite E, Corcoran M, Glahn DC, Jalbrzikowski M. Multimodal Neuroimaging Summary Scores as Neurobiological Markers of Psychosis. Schizophrenia Bulletin. 2024. doi:10.1093/schbul/sbad149
BibTeX
@article{Rodrigue2024,
author = {Rodrigue, Amanda L and Hayes, Rebecca A and Waite, Emma and Corcoran, Mary and Glahn, David C and Jalbrzikowski, Maria},
title = {Multimodal Neuroimaging Summary Scores as Neurobiological Markers of Psychosis},
journal = {Schizophrenia Bulletin},
year = {2024},
doi = {10.1093/schbul/sbad149}
}
EUVIMED